These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21827400)

  • 1. APO2L/TRAIL: new insights in the treatment of autoimmune disorders.
    Anel A; Martinez-Lostao L
    Recent Pat Inflamm Allergy Drug Discov; 2011 Sep; 5(3):184-99. PubMed ID: 21827400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer.
    Martinez-Lostao L; Marzo I; Anel A; Naval J
    Biochem Pharmacol; 2012 Jun; 83(11):1475-83. PubMed ID: 22230480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apo2L/TRAIL and immune regulation.
    Anel A; Bosque A; Naval J; Pineiro A; Larrad L; Alava MA; Martinez-Lorenzo MJ
    Front Biosci; 2007 Jan; 12():2074-84. PubMed ID: 17127445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Following TRAIL's path in the immune system.
    Falschlehner C; Schaefer U; Walczak H
    Immunology; 2009 Jun; 127(2):145-54. PubMed ID: 19476510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into apoptosis signaling by Apo2L/TRAIL.
    Gonzalvez F; Ashkenazi A
    Oncogene; 2010 Aug; 29(34):4752-65. PubMed ID: 20531300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.
    Almasan A; Ashkenazi A
    Cytokine Growth Factor Rev; 2003; 14(3-4):337-48. PubMed ID: 12787570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells.
    De Miguel D; Basáñez G; Sánchez D; Malo PG; Marzo I; Larrad L; Naval J; Pardo J; Anel A; Martinez-Lostao L
    Mol Pharm; 2013 Mar; 10(3):893-904. PubMed ID: 23331277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
    Mitsiades N; Mitsiades CS; Poulaki V; Anderson KC; Treon SP
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1521-30. PubMed ID: 11772267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL.
    Holland PM
    Cancer Lett; 2013 May; 332(2):156-62. PubMed ID: 21220186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.
    Monleón I; Martínez-Lorenzo MJ; Monteagudo L; Lasierra P; Taulés M; Iturralde M; Piñeiro A; Larrad L; Alava MA; Naval J; Anel A
    J Immunol; 2001 Dec; 167(12):6736-44. PubMed ID: 11739488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V; Mitsiades CS; Kotoula V; Tseleni-Balafouta S; Ashkenazi A; Koutras DA; Mitsiades N
    Am J Pathol; 2002 Aug; 161(2):643-54. PubMed ID: 12163389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice.
    Xiang H; Nguyen CB; Kelley SK; Dybdal N; Escandón E
    Drug Metab Dispos; 2004 Nov; 32(11):1230-8. PubMed ID: 15282212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
    Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.
    De Miguel D; Gallego-Lleyda A; Galan-Malo P; Rodriguez-Vigil C; Marzo I; Anel A; Martinez-Lostao L
    Clin Transl Oncol; 2015 Aug; 17(8):657-67. PubMed ID: 25967100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
    Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
    Cretney E; McQualter JL; Kayagaki N; Yagita H; Bernard CC; Grewal IS; Ashkenazi A; Smyth MJ
    Immunol Cell Biol; 2005 Oct; 83(5):511-9. PubMed ID: 16174101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
    Yeow WS; Baras A; Chua A; Nguyen DM; Sehgal SS; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1356-62. PubMed ID: 17140955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.